Randomized and double-blinded pilot clinical study of the safety and anti-diabetic efficacy of the Rauvolfia-Citrus tea, as used in Nigerian Traditional Medicine

Journal of Ethnopharmacology

Volumn 133, Issue 2, 2011, Pages 402-411

  Campbell Tofte, Joan I A ^a,d   Mølgaard, Per ^a   Josefsen, Knud ^b   Abdallah, Zostam ^a   Hansen, Steen Honoré ^a   Cornett, Claus ^a   Mu, Huiling ^a   Richter, Erik A ^c   Petersen, Henning Willads ^c   Nørregaard, Jens Christian ^d   Winther, Kaj ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d FREDERIKSBERG HOSPITAL   (Denmark)

Author keywords

Citrus aurantium; Clinical research; Ethnopharmacology; Herbal remedies; Rauvolfia vomitoria; Type 2 diabetes

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ANTIDIABETIC AGENT; FATTY ACID; HERBACEOUS AGENT; METFORMIN; PLACEBO; PLANT MEDICINAL PRODUCT; REPAGLINIDE; SULFONYLUREA;

ADULT; AGED; ARTICLE; CALORIC RESTRICTION; CLINICAL ARTICLE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLIAGE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MALE; MEDICINAL PLANT; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; RAUVOLFIA VOMITORIA; SKELETAL MUSCLE; SOUR ORANGE; TEA; TRADITIONAL MEDICINE; WEIGHT CHANGE;

AGED; ANIMALS; BEVERAGES; BLOOD GLUCOSE; CITRUS; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ETHNOPHARMACOLOGY; FATTY ACIDS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; MEDICINE, AFRICAN TRADITIONAL; MICE; MIDDLE AGED; MUSCLE, SKELETAL; NIGERIA; PHYTOTHERAPY; PILOT PROJECTS; PLANTS, MEDICINAL; RAUWOLFIA;

CITRUS; CITRUS AURANTIUM; MUS; RAUVOLFIA; RAUVOLFIA VOMITORIA;

EID: 78651399826     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.10.013     Document Type: Article

References (35)

1. L. Abu-Elheiga, M.M. Matzuk, K.A. Abo-Hashema, and S.J. Wakil Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2 Science 291 2001 2613 2616
2. A. Andersson, A. Sjödin, A. Hedman, R. Olsson, and B. Vessby Fatty acid profile of skeletal muscle phospholipids in trained and untrained young men American Journal of Physiology - Endocrinology and Metabolism 279 2000 E744 E751
3. N. Barzilai, and L. Rossetti The relationship between changes in body composition and insulin responsiveness in models of the aging rat American Journal of Physiology 269 1995 E591 E597
4. J.I.A. Campbell, A. Mortensen, and P. Mølgaard Tissue lipid lowering-effect of a traditional Nigerian anti-diabetic infusion of Rauwolfia vomitoria foliage & Citrus aurantium fruit Journal of Ethnopharmacology 104 2006 379 386
5. J.I. Campbell-Tofte, S.H. Hansen, H. Mu, and P. Mølgaard Increased lipids in non-lipogenic tissues are indicators of the severity of type II diabetes in mice Prostaglandins, Leukotrienes and Essential Fatty Acids 76 2007 9 18
6. D. Dean, J.R. Daugaard, M.E. Young, A. Saha, D. Vavvas, S. Asp, B. Kiens, K.H. Kim, L. Witters, E.A. Richter, and N. Ruderman Exercise diminishes the activity of acetyl-CoA carboxylase in human muscle Diabetes 49 2000 1295 1300
7. L. Duvillard, F. Pont, E. Florentin, P. Gambert, and B. Vergs Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus Atherosclerosis 152 2000 229 237
8. J. Gertsch How scientific is the science in ethnopharmacology? Historical perspectives and epistemological problems Journal of Ethnopharmacology 122 2009 177 183
9. A. Golay, L. Zech, M.Z. Shi, Y.A. Chiou, G.M. Reaven, and Y.D. Chen High density lipoprotein (HDL) metabolism in non-insulin dependent diabetes mellitus: measurement of HDL turn-over using tritiated HDL Journal of Clinical Endocrinology & Metabolism 65 1987 512 518
10. N.M. Hadler Oral hypoglycemics and diabetic nephropathy Clinical Journal of the American Society of Nephrology 3 2008 159 162
11. S.M. Haffner, S. Lehto, T. Rönnemaa, K. Pyörälä, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction New England Journal of Medicine 339 1998 229 234
12. S.B. Jørgensen, E.A. Richter, and J.F. Wojtaszewski Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise Journal of Physiology 574 2006 17 31
13. A. Kautzky-Willer, M. Krssak, C. Winzer, G. Pacini, A. Tura, S. Farhan, O. Wagner, G. Brabant, R. Horn, H. Stingl, B. Schneider, W. Waldhäusl, and M. Roden Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes Diabetes 52 2003 244 251
14. R.D. Kealy, D.F. Lawler, J.M. Ballam, S.L. Mantz, D.N. Biery, E.H. Greeley, G. Lust, M. Segre, G.K. Smith, and H.D. Stowe Effects of diet restriction on life span and age-related changes in dogs Journal of the American Veterinary Medical Association 220 2002 1315 1320
15. J.W. Kemnitz, E.B. Roecker, R. Weindruch, D.F. Elson, S.T. Baum, and R.N. Bergman Dietary restriction increases insulin sensitivity and lowers blood glucose in rhesus monkeys American Journal of Physiology 266 1994 E540 E547
16. R.R. Koski Practical review of oral antihyperglycemic agents for type 2 diabetes mellitus The Diabetes Educator 32 2006 869 876
17. V.V. Mistry, and F.V. Kosikowski Influence of potassium sorbate and hydrogen peroxide on psychrotrophic bacteria in milk Journal of Dairy Science 68 1985 605 608
18. D. Moher, K.F. Schulz, D.G. Altman, and CONSORT GROUP (Consolidated Standards of Reporting Trials) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials Annals of Internal Medicine 134 2001 657 662
19. L. Monnier, H. Lapinski, and C. Colette Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c) Diabetes Care 26 2003 881 885
20. K. Node, and T. Inoue Postprandial hyperglycemia as an etiological factor in vascular failure Cardiovascular Diabetology 8 2009 23 33
21. H.K. Ortmeyer In vivo insulin regulation of skeletal muscle glycogen synthase in calorie-restricted and in ad libitum-fed rhesus monkeys Journal of Nutrition 131 2001 907S 912S
22. S.H. Park, S.R. Gammon, J.D. Knippers, S.R. Paulsen, D.S. Rubink, and W.W. Winder Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle Journal of Applied Physiology 92 2002 2475 2482
23. G. Perseghin, P. Scifo, M. Danna, A. Battezzati, S. Benedini, and E. Meneghini Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation American Journal of Physiology Endocrinology and Metabolism 283 2002 E556 E564
24. M. Roden Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes International Journal of Obesity (London) 29 Suppl. 2 2005 S111 S115
25. E. Selvin, M.W. Steffes, H. Zhu, K. Matsushita, L. Wagenknecht, J. Pankow, J. Coresh, and F.L. Brancati Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults New England Journal of Medicine 362 2010 800 811
26. S. Sharma, J.V. Adrogue, L. Golfman, I. Uray, J. Lemm, K. Youker, G.P. Noon, and O.H. Frazier Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart The FASEB Journal 18 2004 1692 1700
27. D. Sviridov, and P. Nestel Dynamics of reverse cholesterol transport: protection against atherosclerosis Atherosclerosis 161 2002 245 254
28. R. Temple Are surrogate markers adequate to assess cardiovascular disease? JAMA 282 1999 790 795
29. L. Tong Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery Cellular and Molecular Life Sciences 62 2005 1784 1803
30. R.C. Turner, H. Millns, H.A.W. Neil, I.M. Stratton, S.E. Manley, D.R. Matthews, R.R. Holman for the United Kingdom Prospective Diabetes Study Group Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) British Medical Journal 316 1998 823 828
31. F. de Vegt, J.M. Dekker, H.G. Ruhé, C.D. Stehouwer, G. Nijpels, L.M. Bouter, and R.J. Heine Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study Diabetologia 42 1999 926 931
32. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation 2000. WHO Technical Report Series 894. World Health Organization, Geneva.
33. C.P. Wilkinson, F.L. Ferris, R.E. Klein, P.P. Lee, C.D. Agardh, M. Davis, D. Dills, A. Kampik, R. Pararajasegaram, J.T. Verdaguer Global Diabetic Retinopathy Project Group Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales Ophthalmology 110 2003 1677 1682
34. V. Woo, M.V. Shestakova, C. Ørskov, and A. Ceriello Targets and tactics: the relative importance of HbA1c, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes International Journal of Clinical Practice 62 2008 1935 1942
35. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M.F. Hirshman, L.J. Goodyear, and D.E. Møller Role of AMP-activated protein kinase in mechanism of metformin action Journal of Clinical Investigation 108 2001 1167 1174